Literature DB >> 7871065

Opioid physical dependence development in humans: effect of time between agonist pretreatments.

K C Kirby1, M L Stitzer.   

Abstract

We examined the effect of morphine pretreatment spacing on intensity of subsequent precipitated withdrawal response to test the hypothesis that withdrawal intensity would be inversely related to pretreatment spacing. Subjects were ten nondependent male volunteers who reported using opioids an average of 2.5 times per week. Three IM morphine injections (each 18 mg/70 kg) were administered during each of four experimental conditions. The experimental conditions involved spacing injections at 12-, 24-, 48- or 72-h intervals. Naloxone (10 mg/70 kg IM) was administered 24 h after the last morphine exposure. A comparison condition was included in which a naloxone challenge was given at 24 h following a single IM morphine pretreatment (18 mg/70 kg). Subject rated measures of symptoms and observer-rated measures of signs indicated that withdrawal intensity was inversely related to the morphine spacing interval and in particular that intensity of withdrawal precipitated after three pretreatments spaced at 12-h intervals was greater than that precipitated after a single morphine pretreatment. Physiological data supported a more intense withdrawal response in the 12-h spacing condition and provided evidence of overshoot on blood pressure and skin temperature measures. These findings are pertinent to the transition between acute and chronic physical dependence; they suggest that there is a temporal window during which repeated opioid administrations result in escalation of physical dependence but that dependence levels after widely spaced multiple exposures may be no greater than after a single exposure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7871065     DOI: 10.1007/bf02244902

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine.

Authors:  I Yano; A E Takemori
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1977-04

2.  Effects of single doses of N-Allylnormorphine on hindlimb reflexes of chronic spinal dogs during cycles of morphine addiction.

Authors:  A WIKLER; R L CARTER
Journal:  J Pharmacol Exp Ther       Date:  1953-09       Impact factor: 4.030

3.  An analysis of naltrexone precipitated abstinence in morphine-dependent chronic spinal dogs.

Authors:  W R Martin; P E Gilbert; D R Jasinski; C D Martin
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

4.  Simultaneous quantitative assessment of morphine tolerance and physical dependence.

Authors:  E L Way; H H Loh; F H Shen
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

5.  Discriminative response control by naloxone in morphine pretreated rats.

Authors:  S Miksic; G Sherman; H Lal
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

6.  Naloxone-precipitated jumping in mice pretreated with acute injections of opioids.

Authors:  J N Wiley; D A Downs
Journal:  Life Sci       Date:  1979-08-27       Impact factor: 5.037

7.  Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II.

Authors:  K C Kirby; M L Stitzer; S J Heishman
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

8.  Acute opioid physical dependence in humans: effect of naloxone at 6 and 24 hours postmorphine.

Authors:  S J Heishman; M L Stitzer; G E Bigelow; I A Liebson
Journal:  Pharmacol Biochem Behav       Date:  1990-06       Impact factor: 3.533

9.  Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo.

Authors:  R R Griffiths; G E Bigelow; I Liebson; J E Kaliszak
Journal:  J Pharmacol Exp Ther       Date:  1980-12       Impact factor: 4.030

10.  Acute physical dependence induced by continuous intravenous infusion of morphine or meperidine in the rat.

Authors:  T Nakaki; M Saito; T Nakadate; Y Tokunaga; R Kato
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more
  9 in total

1.  Episodic withdrawal promotes psychomotor sensitization to morphine.

Authors:  Patrick E Rothwell; Jonathan C Gewirtz; Mark J Thomas
Journal:  Neuropsychopharmacology       Date:  2010-09-01       Impact factor: 7.853

2.  Inhibitory transmission in the bed nucleus of the stria terminalis in male and female mice following morphine withdrawal.

Authors:  Brennon R Luster; Elizabeth S Cogan; Karl T Schmidt; Dipanwita Pati; Melanie M Pina; Kedar Dange; Zoé A McElligott
Journal:  Addict Biol       Date:  2019-04-09       Impact factor: 4.280

Review 3.  Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.

Authors:  Andrew C Harris; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

Review 4.  Reinforcement processes in opiate addiction: a homeostatic model.

Authors:  G Schulteis; G F Koob
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

5.  Divergent behavioral responses in protracted opioid withdrawal in male and female C57BL/6J mice.

Authors:  Isabel M Bravo; Brennon R Luster; Meghan E Flanigan; Patric J Perez; Elizabeth S Cogan; Karl T Schmidt; Zoe A McElligott
Journal:  Eur J Neurosci       Date:  2019-10-06       Impact factor: 3.386

6.  Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.

Authors:  Marc R Azar; Byron C Jones; Gery Schulteis
Journal:  Psychopharmacology (Berl)       Date:  2003-05-29       Impact factor: 4.530

7.  Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history.

Authors:  J L Azolosa; M L Stitzer; M K Greenwald
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

8.  Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure.

Authors:  Patrick E Rothwell; Mark J Thomas; Jonathan C Gewirtz
Journal:  Neuropsychopharmacology       Date:  2009-06-03       Impact factor: 7.853

Review 9.  Endogenous opiates: 1993.

Authors:  G A Olson; R D Olson; A J Kastin
Journal:  Peptides       Date:  1994       Impact factor: 3.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.